All Activity

I stumbled upon the open sea for brainrots discord server and found it buzzing with creative discussions about escape tsunami for brainrots strategies, which made me curious how their game hub blends real-world social issues with virtual challenges.

I heard about the freak circus full game while waiting for my coffee, which made me curious about how such a niche title could be so popular. The workshop at Project Object on October 26th sounds like a great chance to learn from Elly Blue, who’s been in the publishing scene for years.

“The pharmaceutical pathway and the natural medicine pathway are not competing rivers. They are tributaries of the same watershed.” By Shannon Hughes, Elemental Psychedelics via Colorado Newsline Two signatures, 48 hours apart, just changed how psychedelic medicine arrives in America. On April 18, President Donald Trump signed an executive order accelerating federal review of psychedelic drugs for serious mental illness. Within days, the Food and Drug Administration (FDA) awarded three commissioner’s national priority vouchers—to Compass Pathways for psilocybin-assisted therapy in treatment-resistant depression, Usona Institute for psilocybin in major depressive disorder, and Otsuka for methylone (a relative of MDMA) in PTSD. These vouchers may compress what is typically a 10-to-12-month FDA review down to as little as one or two months. On April 20, with far less fanfare, Gov. Jared Polis (D) signed Colorado’s Senate Bill 26-31. The bill specifies that the moment the Drug Enforcement Administration (DEA) reschedules an FDA-approved Schedule I drug, Colorado’s law follows automatically. Pharmaceutical psilocybin will be legal to dispense in Colorado the instant federal approval lands. I’m hopeful about this. Patients with treatment-resistant depression have been waiting a long time. So have veterans with PTSD. So have practitioners who have spent years preparing to do this work with care. I am also worried. Not about what’s coming, but about what we might accidentally let go of in the rush to receive it. SB-31 explicitly carves out natural medicine and marijuana, leaving Colorado’s Proposition 122 framework—the voter-approved natural medicine program with its facilitator-led healing centers—entirely intact. That carve-out matters more than it appears. Most states pursuing psychedelic policy are picking a single lane, choosing between a medical, prescription-based pathway and a community-based, facilitator-led one, as though the two were incompatible. Colorado is choosing both. This is rarer than people realize, and it is more honest about how healing actually works. The pharmaceutical pathway and the natural medicine pathway are not competing rivers. They are tributaries of the same watershed. Different people need different doors. A patient with treatment-resistant depression whose insurance will eventually cover psilocybin-assisted therapy needs one door. Someone seeking to grieve a loss in community, or to find their way back to themselves through ceremony, needs another. Both are legitimate. The question Colorado now faces is not which path wins, but whether we can hold both with integrity as the federal pace quickens. Here is what I worry the temptation will be: Now that medicalized access is coming, perhaps some will think that the work of expanding community access is done. The healing centers, the facilitator licensing, the careful and slow work of Prop 122 implementation—all of it can be de-prioritized, the thinking goes, because patients will soon be able to get psilocybin from a doctor and a pharmacy. This would be a profound mistake. Medicalized access and community access serve different needs, draw on different lineages of knowledge, and answer different kinds of suffering. Collapsing the two is misunderstanding what these medicines are asking of us. The work of reform and opening up access is not done. Colorado voters chose a wider path with Prop. 122. So here is what I would ask in this particular moment. To Colorado legislators and regulators: Keep faith with the voters. The careful work of Prop. 122 implementation—facilitator licensing, healing center regulation, training standards, equitable access, and the ongoing rulemaking around whether and how ibogaine will be incorporated—is exactly the work that makes a wider path real. Fund it. Staff it. Defend it from the gravitational pull of a federal model that will, by virtue of its pace and resources, threaten to absorb everything in its orbit. To my colleagues who will soon be prescribing or administering these medicines: Please, let us not treat psilocybin-assisted therapy as the next SSRI. A one-to-two-month FDA review does not give practitioners one-to-two months to become ready. Genuine readiness to hold non-ordinary states of consciousness with skill, to attend to set and setting, to support the integration that follows, takes far longer than the regulatory clock. Get trained well, and get trained before you prescribe, not after. To Coloradans: The next year of natural medicine rulemaking will shape what Prop. 122 actually delivers in your community. Public input matters here. Show up for it. To other states watching Colorado: A wider path is possible. The federal acceleration does not require abandoning community-based access. It makes protecting it more urgent, not less. The medicines are coming, faster than we expected. The question is whether we will meet them with the depth and care this moment asks of us, and whether we will keep faith with the wider path Coloradans already chose. We can hold both. But only if we choose to. Dr. Shannon Hughes is co-founder and program director of Elemental Psychedelics, a Colorado-based, women-led training organization for psychedelic practitioners. She served as an advisor to the Qualifications, Training, and Licensing Subcommittee of Colorado’s Natural Medicine Advisory Board and co-founded the Colorado nonprofit The Nowak Society. This piece was first published by Colorado Newsline. Photo courtesy of Mark Groeneveld. The post For Psychedelics, The Pharmaceutical And Natural Medicine Pathways Are Both Legitimate—And Compatible (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Where’s our money? I worked really hard, and I want to be paid in full.” By Megan Henry, Ohio Capital Journal Petitioners who tried to get a hemp and marijuana referendum on Ohio’s November ballot are saying they either never got paid or only got partially paid for the signatures they collected. Lisa Flagella and Amanda Ward say they—along with several other petitioners—did not get paid for the signatures they collected for the Ohio Senate Bill 56 referendum effort. The referendum would have overturned the lawmaker-passed overhaul of the adult-use marijuana law passed by voters in 2023. Ultimately the referendum effort did not gather enough signatures to move forward within the necessary timeline for the ballot. Thomas Miller and Pat Manning said they only got partially paid for the signatures they collected. “We made the decision at one point in the campaign to suspend paid signature collection as we assessed how many signatures we had collected at that point because we did have a large grass roots movement of unpaid volunteers collecting signatures,” Dennis Williard, campaign spokesperson, said in an email. Ohioans for Cannabis Choice had more than 5,000 people and businesses pledge to sign, collect, or host places where people could sign the petitions, Williard said. If the referendum made it to the ballot, it would have given voters a chance to overturn a law that went into effect on March 20 that changes Ohio’s voter-passed recreational marijuana law and bans intoxicating hemp products, including THC-infused beverages. Ohioans for Cannabis Choice would not say how many signatures were collected. They needed to collect 248,092 signatures and also needed to gather 3 percent of an individual county’s gubernatorial turnout in 44 of Ohio’s 88 counties to get on the November 3 ballot. The S.B. 56 referendum collected about 208,000 signatures, said Mark Fashian, formerly the president of hemp product wholesaler Midwest Analytical Solutions in Delaware, Ohio. Fashian, who said he helped raise money for the referendum effort, said the number of signatures while testifying during a May 4 injunction hearing of an ongoing lawsuit in the Franklin County Court of Common Pleas. The new law reduces THC levels in adult-use marijuana extracts from a maximum of 90 percent down to a maximum of 70 percent, caps THC levels in adult-use flower to 35 percent, and prohibits smoking in most public places. It also bans possessing marijuana in anything outside of its original packaging and criminalizes bringing legal marijuana from another state back to Ohio. “I believed in the cause,” Flagella said. Ohioans for Cannabis Choice hired ​​Arno Petition Consultant as the lead consultant, a California-based firm run by Michael Arno—who hired Larry Laws of L&R Political Consultants to get petitioners to collect signatures. The Ohio Capital Journal left messages and sent questions to Arno, but he did not respond. Ohio Petitioning Partners, which is owned by Pam Lauter, was hired as a sub-contractor. Lauter said she has not been paid either. “I’m infuriated,” Lauter said in an email. “This was the biggest debacle I have ever been involved with. I am in the same exact boat as everybody else is. I was not in control of this petition drive.” She said her job was to hire people to collect signatures. “The whole thing is shameful,” Lauter said in an email. “The whole thing is embarrassing. And my heart is broken over at [sic] all.” Ohioans for Cannabis Choice didn’t pay people what they were supposed to be paid, claimed Laws, who has been involved in petition work for 30 years. “I don’t think [Ohioans for Cannabis Choice] put out more than $100,000,” he said. “We took care of a lot of people as best we could, but certainly there wasn’t enough money there to take care of everything.” Laws is not optimistic people will be paid. “If it hasn’t happened by now, it’s not going to happen,” he said. The petitioners were reportedly told they would get paid $9 per valid signature. Flagella collected 1,012 signatures for the S.B. 56 referendum in 10 days and has not gotten paid. “Where’s our money?” she said. Flagella could have been paid about $9,000, depending on how many signatures were valid. “I worked really hard, and I want to be paid in full,” she said. “I drove hours away from my house, spent ten hours on my feet, then drove another hour back to my house.” Flagella, Miller, Manning and seven other people sent a demand letter for immediate payment to Lauter, Laws, Arno, and several other people involved in Ohioans for Cannabis Choice on March 27. “This letter serves as a formal demand for the immediate payment of all outstanding wages owed to myself and 9 other petitioners for services rendered during the Ohio SB 56 referendum signature-gathering campaign… Professional petitioners were brought in from California and Florida as well as Ohio that were instructed to stop work and have subsequently been denied their earned pay.” The Ohio Attorney General initially rejected the referendum’s summary language in January, but certified it February 3 after Ohioans for Cannabis Choice made changes to the language. “That really limited our ability to get our signatures,” Fashian said. Ohioans for Cannabis Choice stopped collecting signatures when the money ran out, Laws said. “I was all for shutting it down when I seen that they were delaying [payments],” Laws said. “If I had it my way, I would have shut it down a week earlier.” The paid petitioners were pulled off collecting signatures for the referendum on February 25, Flagella said, even though the deadline to collect signatures was March 19. “We just got started,” Flagella said. “I was ready to pump it up.” Pat Manning said he got paid for most of his signatures, but not all of them. He collected about 1,000 signatures and he said he got paid about $7,000 from Ohio Petitions Partners. “The first two weeks, everybody got paid,” he said. “The last [signature] turn in, nobody got anything.” He turned in about 100 signatures during the last turn in, so he was expecting to be paid an additional $1,000, but he has not received any of that money. “I’m still baffled as to what happened,” Manning said. “I’m very disappointed in the whole thing.” He has been doing petition work for 10 years. “It’s a ridiculous amount of money for the people that really know what they’re doing,” he said. Flagella has been doing petition work for more than 20 years and said she’s “never been so burned.” “I’ve never experienced anything like this before,” she said. “I’ve always gotten paid. I’ve always done an excellent job and I hold myself to very high standards and in the work that I do.” Flagella remembers signing a contract, but has not been able to track it down. The other petitioners the Ohio Capital Journal talked to also said they are unable to access the contracts they signed. “I signed the contract onboarding through this site, and the site is broken,” Flagella said. “I should be able to see my validity. I should be able to retrieve my contract that I signed.” Thomas Miller—who has previously done marijuana petitions in Missouri and Florida—saw a Facebook post about getting involved with the S.B. 56 referendum. “It’s great money when you get paid,” said Miller, who lives in Mansfield. He collected 101 signatures in one day in eight degree temperatures in front of Beyond Hello Cannabis Dispensary in Mansfield to get the initial signatures needed to submit the initial proposal to the Ohio Attorney General. He got paid $540 for those signatures, but he said he should have received $900. “I know my signatures were good because I checked,” Miller said. He then went on to collect an additional 311 signatures and estimated he should have been paid $2,800. “I need my $2,800,” Miller said. “That’s why I got involved in this. It’s quick money, easy money.” Amanda Ward collected about 100 signatures in 16 days and expected to be paid about $900. “It’s very frustrating,” she said. “I felt like I put myself out there for nothing.” Ward planned on using the money from collecting signatures to go take her family on a summer trip to Connecticut and Pennsylvania. “I don’t see that happening,” she said. “It really sucks, but at this point, it’s not even necessarily about the money. It’s about that we were promised something and those conditions weren’t met. I know I’ll probably never see the money.” This story was first published by Ohio Capital Journal. Photo courtesy of Philip Steffan. The post Ohio Marijuana And Hemp Referendum Campaign Failed To Pay For Some Signatures As Promised, Petitioners Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for a very interesting blog. What else may I get that kind of info written in such a perfect approach? I’ve a undertaking that I am simply now operating on, and I have been at the look out for such info. phishing scam recovery education

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. crypto funds recovery assistance

Thanks for the blog post buddy! Keep them coming... live sgp I admire this article for the well-researched content and excellent wording. I got so involved in this material that I couldn’t stop reading. I am impressed with your work and skill. Thank you so much. toto slot

“We thought they were going to come in and do the right thing, and they’re not. They’re doubling down, and they’re lying about it, which is even worse.” By Sophie Nieto-Muñoz, New Jersey Monitor A state appellate court earlier this month sided with two Jersey City cops who say they shouldn’t have been fired for their off-duty cannabis use, but it’s unknown what the next steps are in this yearslong fight over New Jersey’s marijuana legalization law. A spokesman for James Solomon, a Democrat who became the city’s new mayor in January, said the city is reviewing the policies of Solomon’s predecessor, Steve Fulop, who argued that federal law prevents armed police officers from using cannabis at any time. But the officers’ lawyer, Michael Rubas, said the city has refused to return them to their old jobs despite several rulings that they should be reinstated. “I’m very disturbed by the way the Solomon administration has been handling things. We thought they were going to come in and do the right thing, and they’re not,” Rubas said. “They’re doubling down, and they’re lying about it, which is even worse.” Solomon spokesman Nathaniel Styer declined to respond to Rubas’s charges, but indicated the mayor’s view on police officers using cannabis while off duty differs from how the city operated under Fulop. “We are reviewing those policies as they are not in line with our views and values,” said the spokesman, Nathaniel Styer. The dispute dates to 2022, a few months after New Jersey’s legal recreational cannabis market opened. The state Attorney General’s Office told police departments then that the state’s marijuana legalization law does not allow them to discipline officers for using cannabis off duty, but Fulop argued that federal law prohibits anyone who uses a controlled substance from possessing a firearm. In September 2022, two Jersey City cops, Norhan Mansour and Omar Polanco, tested positive for cannabis they claimed they bought on the legal market. The city suspended and then fired them, but administrative law judges and later the state Civil Service Commission sided with the officers and ordered the city to reinstate them. The officers were placed on modified duty in 2024 but they were not returned to their previous positions. The city appealed both rulings, and on May 1, a state appellate panel ruled in the officers’ favor. A separate decision involving a third police officer upheld that officer’s termination because he bought cannabis from an unlicensed individual. Rubas said Mansour and Polanco are each owed hundreds of thousands of dollars in back pay, and have not had their firearm ID cards or their weapons returned to them. Spokespeople for Jersey City did not respond to multiple requests asking about the officers’ guns. A spokesperson for the Attorney General’s Office declined to comment. The officers still have to get their police licenses reissued by the state Police Training Commission, Rubas said, adding that if the city cooperated the officers could be reinstated to their typical posts within a week. Rubas said he’s reached out to the Solomon administration multiple times, including shortly after Solomon took office, to attempt to resolve the issue. He said he was hoping the city’s stance would change once Fulop left office. “Nothing’s changed at all. It’s been worse,” he said. This story was first published by New Jersey Monitor. The post New Jersey Police Fired For Off-Duty Marijuana Use Still Haven’t Been Reinstated Despite Court Ruling In Their Favor appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“This is what we call the ‘Texas whiplash.’ These poor guys don’t know what is going to happen one day to the next. All they want is certainty and to sell their products.” By Paul Cobler, The Texas Tribune Hemp flower buds and rolled joints were piled into boxes and tucked out of public view by the staff of Dream Planet Smoke and Vape last Thursday after the state filed an appeal that triggered an hourslong ban. By Friday, the items were back on the store shelves, and are flying off them once again as customers rush to stock up while they still can, said Leroy Sims, a cashier at the East Austin smoke shop. “My boss is really big on keeping us all informed because he’s aware of the fact that Texas can’t really make its mind up,” Sims said. “We just put stuff in a box until they can make a decision because we can’t send it anywhere else to sell.” Some of the most profitable products at smoke shops around Texas have been forced off store shelves, then allowed back on, then forced off again, then allowed to return—all within a 45-day span—amid a dizzying slew of court actions centered on the state’s ban on smokable hemp products. This ping-ponging regulatory landscape in recent months has injected economic uncertainty into and bled revenue for an industry that employs more than 30,000 people around the state. “This is what we call the ‘Texas whiplash,’” said David Sergi, an attorney for the hemp industry. “These poor guys don’t know what is going to happen one day to the next. All they want is certainty and to sell their products.” While the percentage varied at each shop that spoke to The Texas Tribune, managers and cashiers said smokable hemp products make up a sizable portion of their total profits. The uncertainty surrounding a potential ban on their sales is already leading to employees losing their jobs, hours being cut back and plans being made to close store locations. The ultimate fear is that customers will soon start losing access to some of their favorite products even before the courts permanently rule on the ban. Austin Vape & Smoke is eyeing closing its less popular location near the University of Texas at Austin campus, leaving a handful of employees out of work, and cutting back on hours at their South Austin location, said Zaquiri Hensen, a manager at the South Austin store. About 43 percent of the company’s sales are smokable hemp products. “It…sucks,” Hensen said, using an expletive to emphasize his frustration with the recent uncertainty. “We’re lucky that we don’t really have any turnover, so a lot of our guys have been working here for a long, long time. I’m very close with them.” Texas smoke shops have had the opportunity to plan for a ban because it has already happened twice in recent months as the Texas Department of State Health Services’ efforts to further regulate the consumable hemp industry is challenged in state courts. A statewide ban on the sale of smokable hemp went into effect on March 31 under rules imposed by the public health agency. Smoke shops briefly pulled the products from their shelves until a Travis County district judge on April 10 temporarily lifted the ban until May 1 as a lawsuit by the hemp industry challenged the ban played out in court. Earlier this month, a judge ruled to extend the ban until the next hearing in the district courts, scheduled for July 27, but because the 15th Court of Appeals agreed to considering the state’s appeal, the ban was back in effect last Thursday. That ban only lasted for some hours—briefly forcing the products off store shelves again—until the appeals court last Thursday allowed the sale of the smokable flower. The next ruling on whether or not the injunction will stand is expected in the coming weeks. If the appeals court blocks the injunction, the ban will remain in effect at least until the district court’s July 27 hearing. The regulatory effort to ban smokable hemp began last fall after an effort to completely ban consumable hemp products failed in the Legislature. Lt. Gov. Dan Patrick (R) and other conservative legislators leading the effort argued the products are dangerous to Texans and must be banned. Rather than keep the Legislature in Austin for a special session on the topic, Gov. Greg Abbott (R) ordered DSHS and the Texas Alcoholic Beverage Commission to create stricter regulations on the products, which culminated with the state health agency’s ban of smokable hemp. Abbott referred a request to comment to DSHS, which referred a request for comment to Abbott’s fall executive order. Patrick did not respond to a request for comment. Businesses are working to comply with changing state laws and regulations, all while enforcement raids of smoke shops have picked up in recent years. But following the recent flurry of court actions has proved challenging. “I wasn’t even aware it was illegal because the last I had heard we were good to sell it until July 27,” Anthony Vazquez, owner of Dooby’s Smoking Depot in south-central Austin, said of last week’s hours-long ban. “I didn’t get any messages saying that it was gone. It wasn’t brought to my attention until Friday when I went to my distribution company and they were pulling the stuff back out on roller carts again.” Other smoke shops have been following the court proceedings in group chats with thousands of members created by the state’s largest trade association for the industry and one of the plaintiffs in the case, the Texas Hemp Business Council. Others said they are closely following updates in the news and pass the updates on to their customers. More than half of the sales at Dream Planet are smokable hemp, Sims said, and the company’s three locations may work to transition away from the products regardless of the court rulings because of the ongoing uncertainty. Sam Mafza, a cashier at La Casa Smoke Shop in East Austin, said 50 percent of the sales at his store are smokable hemp, and they have already cut back on hours. Mafza said he has a friend at a different smoke shop who recently lost his job due to the uncertainty. “Everybody is watching this,” Mafza said. “You can’t just abandon a product everybody uses.” The Texas Hemp Business Council, Hemp Industry & Farmers of America, and several Texas-based dispensaries and manufacturers have been fighting the state’s new testing requirements that create a 0.3 percent total THC threshold that would effectively bar the sale of natural smokable hemp products. The state also created a 3,000 percent increase in licensing fees for hemp retailers. During a three-day hearing before the district court on the injunction, attorneys for the state argued that Texas law requires the health agency to prioritize Texans’s well-being in rulemaking, allowing them to implement new hemp regulations. Lawyers for the hemp industry argued that the state’s public health agency overstepped its constitutional authority by rewriting the legal definitions of hemp to make it different from what lawmakers passed in 2019, and the ban would put stores out of business. Cynthia Cabrera, president of the Texas Hemp Business Council, said the effects of a ban go far beyond smoke shops, harming farmers that grow hemp, suppliers that manufacture the products, packaging companies, transportation and consumers. Beau Whitney, the founder and chief economist at Whitney Economics, a cannabis economic research firm, told the district court that the new rules and regulations will have a $7.2 billion negative impact on the Texas economy due to job losses and reduced tax revenue from hemp retail closures. “The ripple effects are far, wide and deep,” Cabrera said. In the meantime, the business council is simply trying to keep its members informed of the fast-moving legal landscape, Cabrera said. While smoke shops await clarity from the courts, many stores are trying to diversify their merchandise, such as hemp edibles and drinks, that will not be banned under the new rules, she said. Many are also trying to move their products through their stores as quickly as possible, offering promotions like buy two get one free for joints and other discounts on smokable flower buds. If a full ban goes into effect, “I just have to take a loss on everything,” Vazquez said. “I’d rather have cash than be stuck with a bunch of weed.” This article first appeared on The Texas Tribune. The post Texas’s On-Again, Off-Again Hemp Product Ban Causes Confusion For Businesses And Consumers appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Regards just for featuring brand-new upgrades in connection with priority, Document wait for look at a great deal more. linen tailor bangkok

“This is a healthcare program. This is for the health of our patients in Alabama, and it says we are not a recreational program.” By Anna Barrett, Alabama Reflector Patients in Alabama with qualifying medical conditions are “days away” from being able to purchase medical cannabis with a physician’s recommendation, according to Vince Schilleci, owner of a dispensary. Callie’s Apothecary in Montgomery will be the first medical cannabis dispensary to open in Alabama. When the program is fully up and running, there will be 12 dispensaries across the state between four companies. “Our goal is to get any questions answered, but get our patients in and out of here quickly, efficiently, do it in a professional manner, but most importantly, be compassionate,” said Vince Schilleci, owner of dispensary Callie’s Apothecary, Thursday morning during a tour. “These patients are dealing with issues, pain, and dealing with them for a while.” Schilleci would not give a specific date for the Montgomery location’s opening because it depends on the testing of the products and delivery. He said the order for the first round of product has been placed from the processor, but when it will be delivered cannot be certain. “We have to remember this product is not like potato chips or something that’s easy to ship, and we have testing that it has to go through. We have to get it into the state’s seed-to-sale tracking system,” Schilleci said. “There’s a lot of moving parts, but we’re close.” Three of the companies, CCS of Alabama, LLC, GP6 Wellness, LLC, and RJK Holdings, LLC, have licenses and are expected to open their storefronts this summer, according to Alabama Medical Cannabis Commission Director John McMillan. A fourth license is pending litigation, but is likely to go to Yellowhammer Medical Dispensaries, LLC. “We’re very anxious to move forward so we can become what the Legislature envisioned, and the public and patients need,” McMillan said in a phone interview Thursday afternoon. The Alabama medical cannabis law, enacted in 2021, allows registered physicians to recommend cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s Disease, PTSD, sickle-cell anemia, chronic pain and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils and gummies (only peach flavor), with raw plant material and smokable forms remaining prohibited. People who suffer from the qualifying conditions must get approval from their physician and enter the patient registry in order to buy products at a dispensary. Litigation has also held up access to medical cannabis. Some firms sued the commission for not being awarded a license, citing a discriminatory process. Another case involved five parents that sued the commission over delays in access to cannabis, which was dismissed in August. McMillan said that there were 181 patients registered with the commission as of Monday. As of Thursday, there are 43 physicians certified to recommend medical cannabis to patients in Alabama, according to the Alabama Board of Medical Examiners. Schilleci said that Callie’s is just waiting on products to be delivered before it can open. Once it does, patients will present their “cannabis card” that their recommending physician will give them in order to enter the storefront. They will then sign in and enter a pharmacy-like room where they can receive consultation from dispensary staff and select a cannabis product. “This is a healthcare program. This is for the health of our patients in Alabama, and it says we are not a recreational program,” Schilleci said. “You just can’t come in here and buy something. You’ve got to go through the process of getting the card and going and making sure you have a qualifying condition.” Schilleci said he is unsure of the total price of each product, but their estimates are lower than their original estimates when they applied. In 2023, Schilleci said CCS estimated that patients would pay $65 for a supply of cuboids, or gummies. “As time moves on and we have more as the processors get comfortable with the program, I think you’ll start seeing the more advanced, gel caps, or maybe transdermal patches, perhaps inhalers and nebulizers and things like that,” Schilleci said. Alora Frank, the area manager at Callie’s, worked in the medical cannabis industry in Florida before moving to Alabama, her home state, to work at the Montgomery dispensary. “On your first visit, there’s a lot of nerves, a lot of fear, there’s a lot of stigma around using this as an alternative medical product. But after their first visit, that second, that third visit, when you start to see people come in and they tell you, ‘Wow, I was able to stop this medication, stop that medication.’ Or you have a patient that had to come in with a wheelchair, and then can come in on their own power. It’s very, very fulfilling,” Frank said. “We are dosing cannabis, but we get doses of humanity back.” Dispensary Locations: CCS of Alabama, LLC Montgomery, Bessemer and Talladega GP6 Wellness, LLC Birmingham, Athens and Attalla RJK Holdings, LLC Oxford, Daphne and Mobile Yellowhammer Medical Dispensary, LLC *pending license approval Birmingham, Owens Cross Roads and Demopolis This story was first published by Alabama Reflector. The post The Launch Of Alabama Medical Marijuana Sales Is Just ‘Days Away,’ With First Dispensary Preparing To Open Its Doors appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I simply believed it might be a concept to publish in case other people had been having issues studying however I'm just a little uncertain basically 'm permitted to place titles as well as handles upon right here. Chiffon print fabric bangkok

Yes, I am entirely agreed with this article, and I just want say that this article is very helpful and enlightening. I also have some precious piece of concerned info !!!!!!Thanks. 성인 피시방

I got too much interesting stuff on your blog. I guess I am not the only one having all the enjoyment here! Keep up the good work. 성인 피시방

i really like this article please keep it up. Tailor who has fabrics for women

Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks 피씨365

Awesome article, it was exceptionally helpful! I simply began in this and I'm becoming more acquainted with it better! Cheers, keep doing awesome! Bangkok proposal photographer

This is my first time i visit here. I found so many interesting stuff in your blog especially its discussion. From the tons of comments on your articles, I guess I am not the only one having all the enjoyment here keep up the good work Tailor with premium fabrics bangkok

Just admiring your work and wondering how you managed this blog so well. It’s so remarkable that I can't afford to not go through this valuable information whenever I surf the internet! Best creative agencies bangkok

Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking. Top 10 cafes bangkok

Such a great breakdown of the pillars! If you want to see this practically, find a BaZi Calculator and pull up your BaZi Chart. It is amazing to see your destiny elements laid out clearly without any guesswork. My BaZi reading gave me so much clarity on my life purpose and the direction I need to take!

A beautiful Aerocity Escort from our agency is all you need to turn a dull evening into a festival. Our handpicked VIP models and air hostesses provide private companionship that arouses passion and offers boundless pleasure. They excel at engaging conversation and intimate moments, making you feel like the center of their universe. Contact us now to book a session that promises unbelievable ecstasy and total relaxation.

A Republican congressman who plans to imminently file legislation to federally regulate hemp-derived products in place of a ban that’s currently scheduled to go into effect later this year says the plan faces opposition from a coalition of strange bedfellows that includes sectors of the alcohol industry, marijuana businesses and cannabis legalization opponents. Rep. Andy Barr (R-KY) said during a Zoom meeting with members of the group Hemp Industry & Farmers of America (HIFA) on Thursday that his bill will create “a regulatory and tax framework” that “would provide a lifeline and a…durable legal pathway for this marketplace,” according to a transcript obtained by Marijuana Moment. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, Trump signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. Barr said the planned recriminalization of hemp THC products would “jeopardize the existing crop that is in storage right now” after having been grown by farmers and would upend “future opportunities to cultivate this this crop.” “So that’s why we need this legislation to establish a regulatory framework and create a level playing field with other similar products, especially in the drink category,” he said, according to the meeting transcript. “We want to create kind of a level playing field with other adult beverages so that farmers will have certainty that they can sell into a mature marketplace with protections that achieves both what we want it to achieve—for safety, for targeting age-appropriate consumers—but also helping our farmers all the way through.” But the effort is facing opposition not just from prohibitionist forces but also from segments of the alcohol industry as well as marijuana businesses that sell cannabis products under limited state-based licensing systems, according to the congressman. Producers of distilled spirits have an “understandable concern about competition” from hemp-derived THC drinks, Barr said. Companies in the wholesale tier of the alcohol industry could be an ally, he added, “because they want to distribute” cannabis beverages. “I think the wholesalers want a three-tier system, so we have worked to try to achieve that with, again, a level playing field where you would have exceptions for direct-to-consumer, where it would make sense that it’s on a state-by-state level,” he said. “We recognize that distilled spirits and other adult beverage groups don’t want competition. That’s natural. But what we want is regulation and tax… We want a level playing field. Competition and choice is something I believe in. And giving consumers choices. Competition’s a good thing… You’re looking at one of the most adamant defenders of the bourbon industry. I’m co-chairman of the Congressional Bourbon Caucus. I don’t think you have to choose. I think you can be an advocate of both hemp products and Kentucky bourbon. So the issue is a level playing field.” “Then you have the prohibitionists,” the congressman said. “And they’re just there, and they may not be persuadable, but they exist.” “And then finally, there’s another category out there, and that’s the marijuana industry that views this as competition as well,” Barr said, per the transcript of the meeting. “They will want to push the industry into specialized dispensaries. My view is that that is not a level playing field. Maybe that’s appropriate for the marijuana industry, but I don’t believe that’s appropriate for this hemp-derived product industry.” Join HIFA & Rep. Andy Barr on TODAY at 3:45 PM ET to discuss the bipartisan LAWFUL HEMP PROTECTION ACT – protecting a $50B+ industry & 475,000+ jobs. Register: https://t.co/KMo9TbD9Y9 pic.twitter.com/S4w7bdTEAR — Hemp Industry & Farmers of America (@hifa_health) May 14, 2026 Barr’s forthcoming bill, which is titled the “Lawful Hemp Protection Act” in draft versions that Marijuana Moment has seen, would institute age limits labeling requirements for hemp products, subject to Food and Drug Administration (FDA) oversight. There would also be taxes on hemp products administered by the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB). Meanwhile, White House officials recently provided Barr’s office with feedback on pending legislation to create a regulatory framework for hemp. Last month, Vince Haley, director of the White House Domestic Policy Council and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to the congressman’s office. “We appreciate your work to advance the policy of” an executive order Trump signed in December that included provisions seeking to protect Americans’ access to CBD products, the staffers wrote in a letter to the congressman. “We are transmitting for your consideration draft legislative text and comments to address the statutory definition of final hemp-derived cannabinoid products in order to allow Americans to benefit from access to appropriate full-spectrum CBD products while preserving the Congress’s intent to restrict the sale of products that pose serious health risks,” the White House officials said, according to a social media post containing a screenshot of the letter. “We are available for discussion and further technical assistance.” The attachment with the administration’s proposed legislative text has not been publicly released, and the White House and Barr’s office did not respond to Marijuana Moment’s requests for further details. At Thursday’s meeting with hemp business representatives, the congressman said there’s “tremendous opportunity in agriculture, in farming, and in this industry generally,” according to the transcript. “I come from Central Kentucky. All four of my grandparents were born and raised in central Kentucky. I was raised in central Kentucky. And once upon a time, that was the burley tobacco capital of the world. Since the decline in tobacco production, our farmers have been looking for alternatives. And industrial hemp and hemp-derived products has created a huge marketplace and tremendous opportunity. And in the consumer marketplace, this has created some choices for consumers. I look forward to working with the industry to provide some stability and certainty so that this industry can be viewed properly as a mature industry, so that there’ll be some durability to the law and decrease the uncertainty that currently exists, so that this market can thrive.” Barr also said cannabis products can provide a safer alternative to prescription medications, especially for military veterans. “To the extent we can promote opioid alternatives or opioid avoidance and help veterans with anxiety or sleep deprivation or insomnia or post-traumatic stress, that’s exactly what we want to do, is to create those options for our veterans to take care of them,” he said. “We think this is a great option for our veteran community.” HIFA officials on the call said they expect Barr’s bill to be filed within the next week, though the expected timeline for the legislation has already shifted back a few times over the past several weeks as Barr has engaged stakeholders, tweaked draft provisions and sought initial cosponsors to join him in introducing the proposal. The House of Representatives recently passed a Farm Bill with provisions aimed at aiding industrial hemp producers—but without any language to delay or alter the federal recriminalization of hemp THC products that’s scheduled to take effect in November. Trump last month pushed congressional lawmakers to take action to amend the currently scheduled hemp ban, which he suggested threatens to federally recriminalize full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” the president said in a Truth Social post on Thursday, the same day his administration announced it is moving forward to reschedule marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Major retailer Target, meanwhile, recently moved to expand its sales of hemp THC drinks into more states. The Wine & Spirits Wholesalers of America (WSWA), for its part, said the House’s failure to include provisions to delay or alter the ban on hemp THC products was a “missed opportunity.” “A ban will not remove these products from the market—it will push consumers toward unregulated, online channels with no age verification, no product standards and no accountability,” Dawson Hobbs, executive vice president of government affairs for WSWA said. The post GOP Congressman Says His Hemp Regulation Bill Faces Opposition From Alcohol, Marijuana And Prohibitionist Groups appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Studies “consistently show” that the non-intoxicating marijuana component CBD is a potential “anticancer agent across different cancer types”—and that effect applies to dogs as well as humans, according to a new systemic review of the scientific literature. Numerous studies have investigated how cannabis and its constituents may impact the symptoms and progression of cancer. The new paper published in the journal Frontiers in Veterinary Science examined that preclinical research, which generally indicates that CBD may “inhibit cell proliferation and migration, while inducing apoptosis in various human tumor cells.” How cannabidiol affects canines has been less rigorously studied compared to humans. That’s despite the fact that the cannabinoid “has been shown to be safe and well-tolerated in dogs, supporting its potential clinical use,” the authors, who are affiliated with the University of Chile, said. They wrote that since 2015, “some studies have been conducted evaluating CBD in different types of canine cancer,” but “no comprehensive review of these findings has been performed.” “For this reason, we conducted a systematic review to compile the existing evidence on the anticancer effects of CBD in dogs,” they said, adding that their analysis determined that preclinical studies, largely based on cellular models, often focus on “lymphoma, mammary cancer, glioma, prostate cancer, osteosarcoma, and urothelial carcinoma.” “These studies consistently show that CBD exerts antiproliferative and proapoptotic effects, in some cases by modulating intracellular signaling pathways,” the review said. “Additionally, some studies have evaluated the combination of CBD with other drugs, reporting both synergistic and antagonistic effects.” “Overall, these findings highlight the potential of CBD as an anticancer agent across different cancer types. However, further studies are required to better elucidate the mechanisms underlying the effects of CBD and to standardize concentrations and formulations, enabling reliable, comparable results and the development of clinical studies evaluating the role of CBD in canine oncology.” The study review builds upon a sizable body of research on the therapeutic potential of cannabis in cancer treatment. For example, another recent scientific review found that CBD “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties. Scientists explored CBD’s effect on many types of cancer—including some of the most aggressive ones, such as glioblastoma, which affects the brain. They also noted it can help suppressing the growth and metastasis of other cancers, including breast, lung, colorectal, ovarian and prostate, among others. In 2025, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. In a sign of greater acceptance of medical applications of cannabis, President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t object to legalization, even if she might not personally agree with the policy. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” With respect to canine research, a case study in the journal Veterinary Medicine and Science published last year suggests that very small doses of the psychedelic LSD appeared to ease a dog’s severe separation anxiety, reducing destructive behavior and shortening the duration of vocalizations. the National Animal Supplement Council (NASC) promoted a study in 2024 that it said shows CBD is “safe for long-term use” in dogs—a significant finding given emerging research that cannabis can effectively treat conditions such as anxiety and certain skin diseases among canines. Another 2024 case study found that cannabis appears to be a “viable alternative” treatment option for dogs suffering from a common skin disease, especially if they experience adverse side effects from conventional steroid therapies. The post CBD Holds Potential As An ‘Anticancer Agent’ For Dogs, New Scientific Review Concludes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Sen. John Fetterman (D-PA) is giving some across-the-aisle credit to President Donald Trump for his administration’s moves to federally reschedule marijuana and accelerate therapeutic access to psychedelics. “I think we could all agree [on] everything that President Trump has done about liberalizing marijuana and psychedelics and now too,” Fetterman said in an interview published by Reason on Wednesday. “I really am very, very libertarian in a lot of ways and for those circumstances,” the senator said. “If you check my record, I’ve been for legal weed for forever in that. Politically, that was toxic or certainly not popular. And also psychedelics too.” “As a libertarian I don’t judge or knock anyone for whatever that they knock their edge off to just make it through in this world,” he said, pointing to his opposition to a crackdown on the nicotine product Zyn, an issue on which he has clashed with other Democrats. “I absolutely support Zyn and those things as long as it’s legal, safe too,” Fetterman said. “I think that’s important. That’s a choice that every American of legal age deserves to have, and to participate in a way that doesn’t turn them into a criminal or judge [them] for those things—make it as safe as possible.” The senator said the right to choose to relax with whatever substances one wants, as long as it doesn’t hurt anybody else, is “sacred.” “Whatever that is. A glass of wine or scotch or sip a little weed, whatever, sitting in front of the fire pit in your backyard.” he said. “Whatever that is. I think your path for wellness, psychedelics, whatever. I think it all should be legal without judgment and without punishment or a criminal record.” “I’ve been very consistent about that and sharing those things,” Fetterman, who has championed cannabis reform since he served as Pennsylvania’s lieutenant governor, said. “So I do hope it continues to liberalize for that, overall.” The Department of Justice last month formally moved state-regulated medical marijuana products from Schedule I of the Controlled Substances Act to Schedule III. A hearing scheduled to begin next month will consider the issue of broader cannabis rescheduling. Also last month, Trump signed executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics. Shortly thereafter, the Food and Drug Administration (FDA) and Department of Health and Human Services (HHS) announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. Fetterman, for his part, has criticized Pennsylvania GOP lawmakers for holding up marijuana legalization as neighboring states like Ohio move forward with the policy change. Last year, the senator’s campaign launched a petition supporting federal marijuana legalization. He previously criticized President Joe Biden for excluding military-level cannabis policy violations from his mass marijuana pardons. The post Fetterman Praises Trump’s Marijuana And Psychedelics Reform Moves appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net